StockData

Earnings calendar

US companies reporting quarterly results in the week of Mar 22 – Mar 26, 2021. Reported figures come from each company's earnings release filed with the SEC; expected dates are estimated from when the company reported in past years.

112 companies · 112 reported

Monday, March 22, 2021

7 companies, largest first · 2 before the open, 2 after the close

CompanyTimeQuarterMarket capRevenueYear agoGrowthEPSYear agoStatus
snxTd SynnexBefore openQ1 FY2021$17.22B–––––Release ↗
dspViant TechnologyAfter closeQ4 FY2020$840.91M–––––Reported
newtNewtekOneDuring marketQ4 FY2020$308.20M–––––Reported
sprbSpruce BiosciencesDuring marketQ4 FY2020$122.75M–––––Reported
irixIridexAfter closeQ4 FY2020$11.94M–––––Reported
rvphReviva PharmaceuticalsBefore openQ4 FY2020$5.90M–––––Reported
vnrxVolitionRxDuring marketQ4 FY2020$2.58M–––––Reported

Tuesday, March 23, 2021

25 companies, largest first · 7 before the open, 8 after the close

CompanyTimeQuarterMarket capRevenueYear agoGrowthEPSYear agoStatus
adbeAdobeDuring marketQ1 FY2021$95.91B–––––Reported
gmeGameStopAfter closeQ4 FY2020$12.19B–––––Reported
airAARAfter closeQ3 FY2021$4.20B–––––Reported
lqdaLiquidiaBefore openQ4 FY2020$3.98B–––––Reported
idyaIDEAYA BiosciencesBefore openQ4 FY2020$2.96B–––––Reported
neogNeogenAfter closeQ3 FY2021$2.55B–––––Reported
trlvTrulieve CannabisBefore openQ4 FY2020$2.10B–––––Reported
slsSELLAS Life SciencesDuring marketQ4 FY2020$1.59B–––––Reported
oricOric PharmaceuticalsAfter closeQ4 FY2020$880.01M–––––Reported
pstlPostal Realty TrustDuring marketQ4 FY2020$653.68M–––––Reported
atyraTYR PHARMAAfter closeQ4 FY2020$591.47M–––––Reported
krroKorro BioBefore openQ4 FY2020$216.91M–––––Reported
paliPalisade BioAfter closeQ4 FY2020$202.15M–––––Reported
curiCuriosityStreamDuring marketQ4 FY2020$149.53M–––––Reported
plbyPlayboyDuring marketQ4 FY2020$148.56M–––––Reported
krmdKORU Medical SystemsAfter closeQ4 FY2020$139.90M–––––Reported
algsAligos TherapeuticsDuring marketQ4 FY2020$56.33M–––––Reported
nsysNortech SystemsDuring marketQ4 FY2020$29.96M–––––Reported
aameAtlantic AmericanDuring marketQ4 FY2020$23.46M$59.93M––$0.54–Release ↗
flnaFilana TherapeuticsBefore openQ4 FY2020$21.79M–––––Reported
ipmIntelligent Protection ManagementBefore openQ4 FY2020$15.09M–––––Reported
bngoBionano GenomicsDuring marketQ4 FY2020$12.95M–––––Reported
fthmFathomAfter closeQ4 FY2020$5.20M–––––Reported
pulmPulmatrixBefore openQ4 FY2020$5.11M–––––Reported
govxGeoVax LabsDuring marketQ4 FY2020$1.16M–––––Reported

Wednesday, March 24, 2021

28 companies, largest first · 11 before the open, 14 after the close

CompanyTimeQuarterMarket capRevenueYear agoGrowthEPSYear agoStatus
gisGeneral MillsBefore openQ3 FY2021$19.49B–––––Reported
jefJefferies FinancialAfter closeQ1 FY2021$11.80B–––––Release ↗
kbhKB HomeAfter closeQ1 FY2021$3.19B–––––Reported
worWorthington EnterprisesBefore openQ3 FY2021$3.18B–––––Release ↗
rhRHAfter closeQ4 FY2020$2.60B–––––Reported
epacEnerpac ToolBefore openQ2 FY2021$2.00B–––––Reported
cnxcConcentrixAfter closeQ1 FY2021$1.90B–––––Reported
hymcHycroft MiningBefore openQ4 FY2020$1.59B–––––Reported
wgoWinnebago IndustriesBefore openQ2 FY2021$937.68M–––––Reported
sanaSana BiotechnologyAfter closeQ4 FY2020$700.50M–––––Reported
ontOnterrisAfter closeQ4 FY2020$681.98M–––––Reported
shoeShoe StationAfter closeQ4 FY2020$412.65M–––––Reported
vitlVital FarmsBefore openQ4 FY2020$408.71M–––––Reported
abeoAbeona TherapeuticsDuring marketQ4 FY2020$223.59M–––––Reported
amwlAmerican WellAfter closeQ4 FY2020$205.98M–––––Reported
mbrxMoleculin BiotechBefore openQ4 FY2020$170.04M–––––Reported
ltbrLightbridgeAfter closeQ4 FY2020$149.46M–––––Reported
railFreightCar AmericaBefore openQ4 FY2020$136.08M–––––Reported
ftcoFortitude GoldDuring marketQ4 FY2020$130.39M–––––Reported
eqEquilliumAfter closeQ4 FY2020$84.33M–––––Reported
lglLGLBefore openQ4 FY2020$82.62M–––––Reported
leatLeattBefore openQ4 FY2020$68.53M–––––Reported
telaTELA BioAfter closeQ4 FY2020$35.02M–––––Reported
msgmMotorsport GamesDuring marketQ4 FY2020$19.59M–––––Reported
ntrpNextTripAfter closeQ4 FY2020$16.11M–––––Reported

Thursday, March 25, 2021

46 companies, largest first · 16 before the open, 20 after the close

CompanyTimeQuarterMarket capRevenueYear agoGrowthEPSYear agoStatus
driDarden RestaurantsBefore openQ3 FY2021$26.09B–––––Release ↗
saicScience Applications InternationalAfter closeQ4 FY2021$6.15B–––––Release ↗
rlayRelay TherapeuticsAfter closeQ4 FY2020$3.73B–––––Reported
vrdnViridian Therapeutics, Inc.\DEDuring marketQ4 FY2020$3.23B–––––Reported
admaADMA BiologicsDuring marketQ4 FY2020$2.96B–––––Reported
fulFuller H BDuring marketQ1 FY2021$2.70B–––––Reported
imnmImmunomeAfter closeQ4 FY2020$2.03B–––––Reported
hrmyHarmony BiosciencesBefore openQ4 FY2020$1.89B–––––Reported
trviTrevi TherapeuticsDuring marketQ4 FY2020$1.83B–––––Reported
prgsProgress SoftwareAfter closeQ1 FY2021$1.82B–––––Release ↗
rexRex American ResourcesBefore openQ4 FY2020$1.30B–––––Reported
annxAnnexonBefore openQ4 FY2020$818.80M–––––Reported
crvsCorvus PharmaceuticalsBefore openQ4 FY2020$818.50M–––––Reported
fdmt4D Molecular TherapeuticsAfter closeQ4 FY2020$812.02M–––––Reported
paysPaysignAfter closeQ4 FY2020$808.54M–––––Reported
movMovadoBefore openQ4 FY2021$695.92M–––––Release ↗
momoHelloDuring marketQ4 FY2020$693.65M–––––Release ↗
lmbLimbachDuring marketQ4 FY2020$649.91M–––––Reported
fthFaeth TherapeuticsBefore openQ4 FY2020$514.74M–––––Reported
ngneNeurogeneAfter closeQ4 FY2020$513.29M–––––Reported
oxmOxford IndustriesAfter closeQ4 FY2020$455.04M–––––Release ↗
mnprMonopar TherapeuticsBefore openQ4 FY2020$451.19M–––––Reported
arkoARKOBefore openQ4 FY2020$433.04M–––––Reported
vreofVireo GrowthBefore openQ4 FY2020$433.00M–––––Reported
krosKeros TherapeuticsBefore openQ4 FY2020$187.37M–––––Reported

Friday, March 26, 2021

6 companies, largest first · 2 before the open, 2 after the close

CompanyTimeQuarterMarket capRevenueYear agoGrowthEPSYear agoStatus
joyyJOYYBefore openQ4 FY2020$4.00BCN¥3.78B––-1.86 CNY–Release ↗
tciTranscontinental Realty InvestorsDuring marketQ4 FY2020$440.63M–––––Reported
arlAmerican Realty InvestorsDuring marketQ4 FY2020$347.59M–––––Reported
duotDuos TechnologiesAfter closeQ4 FY2020$148.86M–––––Reported
mrmdMariMedBefore openQ4 FY2020$22.97M–––––Reported
codxCo-DiagnosticsAfter closeQ4 FY2020$1.67M–––––Reported

Times are as filed with the SEC (before 9:30 a.m. or after 4 p.m. Eastern). See each company's Earnings tab for its full history and guidance, or the dividend calendar. Market caps as of the close on Nov 5, 2026.